Overview
Body Protection Compound-157 (BPC-157) is a synthetic pentadecapeptide consisting of 15 amino acids (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) derived from a naturally occurring protein found in human gastric juice. Originally isolated from gastric secretions, BPC-157 represents the stable, active terminal fragment of the larger Body Protection Compound that contributes to gastric cytoprotection and mucosal integrity.
This peptide has gained considerable attention in regenerative medicine due to its demonstrated pleiotropic beneficial effects in preclinical models, particularly in tissue healing, vascular repair, and inflammatory modulation. BPC-157 exhibits remarkable stability in human gastric juice and maintains bioactivity across various physiological conditions, making it unique among therapeutic peptides.
Chemical structure & Properties
Molecular Formula: C62H98N16O22
Molecular Weight: 1419 Da
Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Half-life: Less than 30 minutes (hepatic metabolism)
Stability: Resistant to gastric acid degradation, stable in human gastric juice
Regulatory Status and
Legal Considerations
FDA Status
Classification: Previously listed as Category 2. Nominated but withdrawn as of April 22, 2026
Approval Status: Not approved for human therapeutic use
Compounding: Standard 503A/503B pharmacy regulations now apply. Consult current FDA guidance before compounding.
Regulatory Position: Insufficient evidence for safety determination
WADA Status
Classification: Prohibited under S0: Non-Approved Substances
Athletic Use: Banned in competitive sports
Testing: Detectable in anti-doping screenings
Legal Availability
Commercial Status: Not legally available as prescription medication
Market Presence: Sold as "research chemicals" or "dietary supplements"
Quality Control: No regulatory oversight for purity or potency
Clinical Use: Limited to research settings and experimental protocols
The Paragon Method: Step-by-Step
Clinical Considerations
Important Notes:
No FDA-approved dosing guidelines exist for human use
Individual response may vary significantly
Medical supervision recommended for any therapeutic application
Quality and purity of commercially available products not guaranteed
Priority Research Areas
Large-scale human clinical trials for safety and efficacy determination
Standardized dosing protocols for various clinical applications
Long-term safety studies including carcinogenicity assessment
Mechanism elucidation of molecular targets and pathways
Drug interaction studies with commonly prescribed medications
Emerging Applications
Research is investigating potential applications in:
Traumatic brain injury and neuroprotection
Wound healing and post-surgical recovery
Age-related degenerative conditions
Metabolic disorders and diabetes complications
Conclusion
BPC-157 represents a promising therapeutic peptide with demonstrated benefits in preclinical models of tissue healing, inflammation, and vascular repair. Its unique mechanism of action through multiple molecular pathways offers potential advantages in regenerative medicine applications. However, the current evidence base remains predominantly preclinical, with limited human clinical data available.
The lack of FDA approval, potential safety concerns, and regulatory restrictions necessitate careful consideration and medical supervision for any therapeutic application. Patients interested in BPC-157 therapy should engage in thorough discussions with qualified healthcare providers to weigh potential benefits against risks and explore evidence-based treatment alternatives.
Future research will be critical in establishing the safety, efficacy, and appropriate clinical applications of BPC-157 in human medicine. Until comprehensive clinical trials are completed, its use should remain limited to research settings and experimental protocols under appropriate medical oversight.
BPC-157 SCIENTIFIC
DATA SUMMARY
Parameter
Molecular Weight
Amino Acid Length
Half-Life
Bioavailability
Detection Window
Value
1,419 Da
15 residues
<30 minutes (hepatic)
Stable in gastric juice
Up to 4 days (urine)
Application
Tendon Healing
Gastric Protection
Angiogenesis
Anti-inflammatory
Studies
8+ studies
15+ studies
6+ studies
10+ studies
Dose Range
1-20 μg/kg
10 ng/kg-10 μg/kg
0.1-100 μg local
1-10 μg/kg
Outcome
Enhanced tensile strength, accelerated repair
Reduced ulceration, improved barrier function
Increased vessel density, VEGF upregulation
Reduced IL-6, TNF-α, COX-2 expression
Study Type
Phase I Trial
Knee Pain Study
Bladder Pain Pilot
Population
42 healthy volunteers
12 patients
12 women
Results
Results not published
11/12 reported improvement
Subjective improvement
Limitations
Study terminated 2016
No standardized measures
No objective endpoints
Parameter
Acute Toxicity
Organ Toxicity
Adverse Events
Long-term Safety
Finding
No LD50 established (6 μg/kg to 20 mg/kg tested)
No histologic changes in major organs
Minimal reported in animal studies
Limited human data available
Authority
FDA
WADA
DEA
Classification
Category 2 Bulk Drug
S0 Non-approved Substance
Unscheduled
Status
Not approved for human use
Prohibited in sports
Not controlled substance
Peptides work best as one part of a complete, medically supervised plan. Many patients pair these with our regenerative treatments, including PRP and bone marrow concentrate (BMAC). To see how this fits your goals, explore our full approach to peptide therapy in Atlanta.
Disclaimer: This information is provided for educational purposes only and does not constitute medical advice. BPC-157 is not approved by the FDA for human therapeutic use. Patients should consult with qualified healthcare providers before considering any peptide therapy.
The content reflects current scientific literature and regulatory status as of April 22–23, 2026
Explore Peptide Therapy at Paragon
Peptides work best as part of a bigger plan, not on their own. At Paragon Sports Medicine in Atlanta, every peptide is prescribed by our team, guided by your labs and your goals, and matched to the right protocol for you. If you are wondering whether this one fits where you want to go, our peptide therapy program in Atlanta is the place to start.